Business Description
BlackRock Health Sciences Trust II
NAICS : 523920
SIC : 6799
ISIN : US09260E1055
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.97 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 6/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60 | |||||
3-Year EPS without NRI Growth Rate | -60.3 | |||||
3-Year Book Growth Rate | -16.5 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.84 | |||||
9-Day RSI | 56.48 | |||||
14-Day RSI | 51.72 | |||||
6-1 Month Momentum % | 2.51 | |||||
12-1 Month Momentum % | 12.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 10.29 | |||||
Forward Dividend Yield % | 13.63 | |||||
5-Year Yield-on-Cost % | 10.29 | |||||
3-Year Average Share Buyback Ratio | 1.9 | |||||
Shareholder Yield % | 11.89 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 115.03 | |||||
FCF Margin % | -849.35 | |||||
ROE % | -1.16 | |||||
ROA % | -1.13 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 0.89 | |||||
Price-to-Free-Cash-Flow | 9.89 | |||||
Price-to-Operating-Cash-Flow | 9.89 | |||||
EV-to-Revenue | -93.9 | |||||
EV-to-FCF | 11.05 | |||||
FCF Yield % | 10.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BMEZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BlackRock Health Sciences Trust II Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | -19.694 | ||
EPS (TTM) ($) | -0.212 | ||
Beta | 1.01 | ||
Volatility % | 17.97 | ||
14-Day RSI | 51.72 | ||
14-Day ATR ($) | 0.211177 | ||
20-Day SMA ($) | 15.5299 | ||
12-1 Month Momentum % | 12.12 | ||
52-Week Range ($) | 13.77 - 16.59 | ||
Shares Outstanding (Mil) | 103.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BlackRock Health Sciences Trust II Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BlackRock Health Sciences Trust II Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
BlackRock Health Sciences Trust II Frequently Asked Questions
What is BlackRock Health Sciences Trust II(BMEZ)'s stock price today?
When is next earnings date of BlackRock Health Sciences Trust II(BMEZ)?
Does BlackRock Health Sciences Trust II(BMEZ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |